Middle East Respiratory Syndrome coronavirus (MERS CoV): Update 2013

被引：15
作者：
Lim, Poh Lian [1 ,2 ]
Lee, Tau Hong [1 ]
Rowe, Emily K. [1 ]
机构：
[1] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore
[2] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore
来源：
CURRENT INFECTIOUS DISEASE REPORTS | 2013年 / 15卷 / 04期
关键词：
Middle East Respiratory Syndrome coronavirus (MERS CoV); Coronavirus; Respiratory illness; SARS; PNEUMONIA;
D O I：
10.1007/s11908-013-0344-2
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Middle East Respiratory Syndrome coronavirus (MERS CoV) came to attention as an emerging pathogen causing severe respiratory illness in patients from the Middle East in September 2012. As of 14 June 2013, 58 human cases of MERS CoV infection have been confirmed, including 33 deaths (case fatality rate of 57%). MERS CoV is a betacoronavirus, in the same family as SARS-CoV, and shares a probable origin from bats. No animal reservoir or intermediates have been definitely implicated in transmission. Limited human-to-human transmission has occurred within several clusters, as individuals without a recent travel history have become infected after exposure to an ill returned traveler.
引用
收藏
页码：295 / 298
页数：4
相关论文
共 50 条
  • [41] Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques
    de Wit, Emmie
    Rasmussen, Angela L.
    Falzarano, Darryl
    Bushmaker, Trenton
    Feldmann, Friederike
    Brining, Douglas L.
    Fischer, Elizabeth R.
    Martellaro, Cynthia
    Okumura, Atsushi
    Chang, Jean
    Scott, Dana
    Benecke, Arndt G.
    Katze, Michael G.
    Feldmann, Heinz
    Munster, Vincent J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (41) : 16598 - 16603
  • [42] Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting
    Abdirizak, Fatima
    Lewis, Rayleen
    Chowell, Gerardo
    THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2019, 16 (01)
  • [43] Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
    Aljabr, Waleed
    Alruwaili, Muhannad
    Penrice-Randal, Rebekah
    Alrezaihi, Abdulrahman
    Harrison, Abbie Jasmine
    Ryan, Yan
    Bentley, Eleanor
    Jones, Benjamin
    Alhatlani, Bader Y.
    AlShahrani, Dayel
    Mahmood, Zana
    Rickett, Natasha Y.
    Alosaimi, Bandar
    Naeem, Asif
    Alamri, Saad
    Alsran, Hadel
    Hamed, Maaweya E.
    Dong, Xiaofeng
    Assiri, Abdullah M.
    Alrasheed, Abdullah R.
    Hamza, Muaawia
    Carroll, Miles W.
    Gemmell, Matthew
    Darby, Alistair
    Donovan-Banfield, I'ah
    Stewart, James P.
    Matthews, David A.
    Davidson, Andrew D.
    Hiscox, Julian A.
    MSPHERE, 2021, 6 (04)
  • [44] Middle east respiratory syndrome corona virus (MERS CoV): The next steps
    Iype Joseph
    Journal of Public Health Policy, 2015, 36 : 318 - 323
  • [45] Middle East respiratory syndrome coronavirus (MERS-CoV): A cluster analysis with implications for global management of suspected cases
    Memish, Ziad A.
    Al-Tawfiq, Jaffar A.
    Alhakeem, Rafat F.
    Assiri, Abdullah
    Alharby, Khalid D.
    Almahallawi, Maher S.
    Alkhallawi, Mohammed
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2015, 13 (04) : 311 - 314
  • [46] Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors
    Kumar, Vathan
    Shin, Jin Soo
    Shie, Jiun-Jie
    Ku, Keun Bon
    Kim, Chonsaeng
    Go, Yun Young
    Huang, Kai-Fa
    Kim, Meehyein
    Liang, Po-Huang
    ANTIVIRAL RESEARCH, 2017, 141 : 101 - 106
  • [47] Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
    Badawi, Alaa
    Ryoo, Seung Gwan
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 49 : 129 - 133
  • [48] Risk of global spread of Middle East respiratory syndrome coronavirus (MERS-CoV) via the air transport network
    Gardner, Lauren M.
    Chughtai, Abrar A.
    MacIntyre, C. Raina
    JOURNAL OF TRAVEL MEDICINE, 2016, 23 (06)
  • [49] The use of DPP-4 inhibitors in the treatment of Middle East respiratory syndrome-coronavirus (MERS-CoV)
    Stoimenis, D.
    ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (01): : 111 - 112
  • [50] Performance and clinical validation of the RealStar® MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA
    Corman, Victor Max
    Oelschlaeger, Stephan
    Wendtner, Clemens-Martin
    Drexler, Jan Felix
    Hess, Markus
    Drosten, Christian
    JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (02) : 168 - 171
12345